Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...

The S&P 500 won't pull back next year as the market enters the third year of a cyclical bull run, Brian Belski said.

Brian Belski, chief investment strategist at BMO Capital Markets, joins 'Halftime Report' to lay out his case for his firm's ...

After two years of annual gains topping 20% for the S&P 500, Wall Street experts anticipate a moderate performance in 2025.

Goldman Sachs sees the S&P 500 gaining 11% over the next year as stock market gains continue to broaden out from a few large ...

After two years of massive gains in the S&P 500, one of Wall Street's biggest bulls thinks the rally will take a "breather" ...

Pfizer Inc. named oncology research head Chris Boshoff as the drug company’s chief scientific officer, replacing Mikael ...

Donald Trump’s presidential win is likely to be gold positive in the medium term, according to John Reade, chief market ...

Banks raised $23.5 billion by issuing investment-grade bonds on Tuesday, the biggest debt issuance by financial institutions ...

American Rare Earths Limited (ASX: ARR \| OTCQX: ARRNF \| ADR: AMRRY) ("ARR" or "the Company") is excited to announce the engagement of BMO ...

The Offering is expected to close on or about November 27, 2024 and is subject to Endeavour receiving all necessary regulatory approvals and the approval of the Toronto Stock Exchange and the New York ...